Emerging Medical Technologies
This website provides licensing guidance for emerging medical technologies. The licensing guidance consists of general licensing considerations, specific radiation safety aspects of the emerging medical technology, and training and experience expectations for those authorized to use the emerging medical technology. This website may also help stakeholders who are developing new methods and technologies that may one day be used to treat medical patients. It also contains a record of the emerging medical technologies whose use has been evaluated for licensing by the NRC. Contact Us to submit medical-related inquiries.
On this page:
NRC Regulation of Emerging Medical Technologies
Title 10 of the
Code of Federal Regulations Part 35, Subpart K – Other Medical Uses of Byproduct Material or Radiation From Byproduct Material (
10 CFR 35.1000) describes the process to obtain a license, or an amendment to a license, for a new medical use of byproduct material or radiation from byproduct material, which is not addressed in other parts of 10 CFR Part 35 (i.e., an emerging medical technology). Additional requirements are included in
10 CFR 35.12(d), "Application for license, amendment, or renewal."
Status of NRC Review of Emerging Technologies
Below is an Emerging Technologies Table: a current list of emerging technologies, status, and links to corresponding documents.
Note: New entries will be added as additional emerging technologies are identified. Licensing guidance will be updated when necessary to address comments from stakeholders. To submit comments on or inquire about a specific licensing guidance document, contact the individual listed in that document or contact us using our electronic form. If applicable, you can also contact the appropriate NRC Regional Office or Agreement State for assistance.
This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.
Page Last Reviewed/Updated Friday, March 11, 2022